找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 2020Latest edition Springer Nature Switzerland AG 2020 Hodgkin Lymph

[復(fù)制鏈接]
樓主: industrious
41#
發(fā)表于 2025-3-28 15:26:45 | 只看該作者
42#
發(fā)表于 2025-3-28 19:59:22 | 只看該作者
Treatment of Early Favorable Hodgkin LymphomaHodgkin lymphoma became highly curable with large radiotherapy fields but at the cost of high early and late toxicity resulting in reduced long-term survival. The successful introduction of multiagent chemotherapy in Hodgkin lymphoma made it possible to combine chemotherapy with radiotherapy in smal
43#
發(fā)表于 2025-3-29 02:30:54 | 只看該作者
Treatment of Early Unfavorable Hodgkin Lymphomatinal mass, extranodal disease, high ESR, or more than three or four nodal areas involved. In addition, selected stage IIB patients are also included in this risk group. The treatment for these patients is based on four cycles of ABVD chemotherapy followed by involved-field radiotherapy or a more ag
44#
發(fā)表于 2025-3-29 03:12:48 | 只看該作者
Treatment of Advanced-Stage Hodgkin Lymphomase within 5 years. Thus, remission rates in excess of 50% achieved with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) were a major breakthrough in oncology when first seen over 40 years ago. Systematic searches for more effective regimens have replaced MOPP by ABVD (doxorubicin,
45#
發(fā)表于 2025-3-29 07:47:28 | 只看該作者
46#
發(fā)表于 2025-3-29 13:21:05 | 只看該作者
Pediatric Hodgkin Lymphomary driving force for this divergence over the last 15–20 years has been a desire to reduce the burden of treatment with particular reference to late effects. That reduction is being achieved primarily by limiting the amount of radiotherapy required to maintain excellent EFS rates. Titration of thera
47#
發(fā)表于 2025-3-29 17:38:14 | 只看該作者
48#
發(fā)表于 2025-3-29 23:47:26 | 只看該作者
49#
發(fā)表于 2025-3-30 02:02:26 | 只看該作者
Henrik Hjalgrim,Ruth F. Jarrettocesses; transition arrays between level ensembles (configurations, superconfigurations); effective temperatures of configurations, superconfigurations, and ions; charge-state distributions; radiative power losses and opacity. There are many numerical examples and comparisons with experiment present
50#
發(fā)表于 2025-3-30 07:48:01 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 21:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
诏安县| 天镇县| 南漳县| 凤城市| 清河县| 扶沟县| 长岛县| 民和| 洛隆县| 江川县| 海城市| 南溪县| 丹凤县| 来安县| 澄城县| 永春县| 宜君县| 大安市| 平武县| 密云县| 天柱县| 化德县| 横峰县| 筠连县| 达孜县| 洛川县| 突泉县| 漳浦县| 凤台县| 临沂市| 云浮市| 长顺县| 会宁县| 环江| 无极县| 家居| 尉犁县| 深水埗区| 高平市| 互助| 冷水江市|